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Annexin-enriched osteoblast-
derived vesicles act as an 
extracellular site of mineral 
nucleation within developing stem 
cell cultures
O. G. Davies1,2, S. C. Cox2, R. L. Williams2, D. Tsaroucha2, R. M. Dorrepaal3, M. P. Lewis1 &  
L. M. Grover2
The application of extracellular vesicles (EVs) as natural delivery vehicles capable of enhancing tissue 
regeneration could represent an exciting new phase in medicine. We sought to define the capacity of 
EVs derived from mineralising osteoblasts (MO-EVs) to induce mineralisation in mesenchymal stem cell 
(MSC) cultures and delineate the underlying biochemical mechanisms involved. Strikingly, we show 
that the addition of MO-EVs to MSC cultures significantly (P < 0.05) enhanced the expression of alkaline 
phosphatase, as well as the rate and volume of mineralisation beyond the current gold-standard, BMP-
2. Intriguingly, these effects were only observed in the presence of an exogenous phosphate source. 
EVs derived from non-mineralising osteoblasts (NMO-EVs) were not found to enhance mineralisation 
beyond the control. Comparative label-free LC-MS/MS profiling of EVs indicated that enhanced 
mineralisation could be attributed to the delivery of bridging collagens, primarily associated with 
osteoblast communication, and other non-collagenous proteins to the developing extracellular matrix. 
In particular, EV-associated annexin calcium channelling proteins, which form a nucleational core with 
the phospholipid-rich membrane and support the formation of a pre-apatitic mineral phase, which was 
identified using infrared spectroscopy. These findings support the role of EVs as early sites of mineral 
nucleation and demonstrate their value for promoting hard tissue regeneration.
Bone fractures present a growing worldwide medical and socioeconomic burden, with 8.9 million reported annu-
ally solely as a result of osteoporosis1. Despite the natural regenerative capacity of bone, there are instances where 
healing is impaired and clinical intervention becomes essential. Examples include when the quantity of bone 
required is simply beyond the body’s natural regenerative capacity, such as in the case of critical sized bone defects 
resulting from trauma or invasive surgeries (e.g. osteosarcoma excision), delayed or non-unions, or when the 
natural regenerative capacity is impaired due to osteoporosis or avascular necrosis2. Standard clinical approaches 
currently used to stimulate or augment bone regeneration include distraction osteogenesis and bone transport, 
autologous or allogeneic bone grafts, or the application of bone graft substitutes (BGS) sometimes combined 
with hyper-concentrated growth factors, such as bone morphogenetic proteins (BMPs) – for example INFUSE® 
grafts3. Although these methods are used in clinical practice with positive results, each suffers from significant 
limitations and even promising osteoinductive approaches utilising the growth factor BMP-2 have been subject 
to controversy and serious negative outcomes4. This means that although current interventions offer a valuable 
method to facilitate bone repair, none of these approaches can be considered optimal and potent methods of 
inducing osteogenesis that are able to rapidly generate bone without associated patient morbidity are required5.
Modern tissue engineering approaches for hard tissue formation have been the subject of substantial research 
over the past two decades, with recent advances in therapies that combine osteoconductive materials with cells 
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providing novel ways of promoting osteogenesis6. Cell-based approaches are appealing since they attempt to 
recapitulate and exploit the body’s natural regenerative capacity and to date there have been a number of signifi-
cant advances made in orthopaedics in this area7. However, it has become increasingly clear that the considerable 
benefits offered by cell-based approaches will be difficult to translate into clinical practice since progression is 
frequently hindered by significant and sometimes insurmountable hurdles associated with ethics, government 
regulation, and high associated costs8. With this in mind, there is considerable merit in developing new biological 
methods of bone regeneration that retain the considerable benefits of a cell-based approach.
Many of the beneficial effects once attributed to cells are now thought to be, at least in part, a consequence of 
paracrine factors packaged within extracellular vesicles (EVs)9. Over the past decade, the importance of EVs in 
cell-cell communication and tissue regeneration has become increasingly recognised. With this in mind, it has 
been recently suggested that the use of EVs for regenerative medicine could be the next logical progression in 
the field10,11. Nowhere is the critical developmental role of EVs more obvious than in the skeletal system, where 
EVs have historically been associated with sites of early mineral formation12,13. EVs act as means of mediating 
communication between osteoblasts and osteoclasts to maintain bone homeostasis. As such, vesicular trafficking 
is important during bone modelling and remodelling, with osteoblasts shown to use vesicles for the transport of 
RANKL to osteoclast precursors to stimulate osteoclast formation14. Similarly, osteoclast-derived EVs have been 
implicated as inhibitors of osteoblast activity through the transfer of miRNA15 as well as paracrine regulators of 
osteoclastogenesis, possibly through competitive inhibition of RANKL16. At present, the application of EVs as 
a therapeutic vehicle for the delivery of regeneration-enhancing biological cargos is only just becoming appar-
ent17. The proposition of applying EVs for regenerative medicine presents considerable benefits over traditional 
cell-based approaches, with conversion upon implantation. In addition, there are thought to be fewer immu-
nological risks associated with the delivery of EVs, due to the fact that induced pluripotent stem cell-derived 
exosomes have previously been shown to lack MHC class I and II proteins18,19. Furthermore, much like stem cells 
or osteoinductive growth factors, EVs have the capacity to be incorporated into materials-based delivery systems 
to enhance tissue formation20. Given the potential benefits of EVs, it is surprising that, to date, only a limited 
number of studies have sought to utilise these valuable factors for regenerative medicine applications21,22. We 
propose that there is considerable utility in the application of osteoblast-derived EVs as a source of osteoinductive 
components that can promote osteogenesis for hard tissue regeneration.
In this study we analysed the potential for osteoblast-derived EVs to act as acellular biological vehicles for 
the delivery of pro-osteogenic cargos able to induce mineralised tissue formation in human bone marrow stem 
cell (hBMSC) cultures. Proteomic analysis of EVs derived from mineralising (MO-EVs) and non-mineralising 
osteoblasts (NMO-EVs) was performed to define how culture status influenced their resulting biological con-
tents. By administering EVs to hBMSC cultures we determined how these biological differences influenced their 
pro-osteogenic effects and compared them with the current gold-standard, BMP-2. Finally, by applying a com-
bination of biological and advanced physical techniques we were able to probe the fundamental mechanisms 
underlying EV-mediated mineralisation within the developing extracellular matrix to identify these vesicles as 
sites of mineral nucleation and development.
Results
Extracellular vesicles can be isolated from the culture medium of mineralising osteoblasts. 
EVs were isolated using differential centrifugation from the spent culture medium of mineralising osteoblasts 
(MO) at two day intervals over a total period of 14 days, as previously described23. The presence of EVs was first 
confirmed by immobilising vesicles on negatively charged mica surfaces for atomic force microscopy (AFM) 
analysis. Intact nano-particles (Fig. 1a) that could be immobilised electrostatically and presented a size range 
of between 79–171 nm were identified using AFM. Particles did not all appear spherical, likely due to previ-
ously documented surface interactions occurring between the EVs and the mica surface24. Direct Light Scattering 
(DLS, Malvern Instruments), tuneable resistive pulse sensing (IZON qNano) and nanoparticle tracking anal-
ysis (Nanosight, Malvern Instruments, Supplementary information S1) confirmed the presence of EVs with a 
mean diameter below 200 nm, correlating with diameters previously documented for exosomes and excluding 
the presence of apoptotic bodies and any larger components of the micro-vesicle fraction25. Average measure-
ments of 157 nm (DLS) and 167 nm (Izon qNano) were obtained (Fig. 1b and c), which highlighted previously 
recognised variation between these methods related to their methodology as well as heterogeneity within the 
final EV fraction. The fraction was largely mono-disperse, with a bell shaped curve recording particle sizes 
between 30–340 nm. The presence of particles above the documented size of exosomes was noted but observed 
sizes were in line with bone-derived vesicles previously published in the literature (≤300 nm)26. In order to not 
further growing confusion regarding EV definitions within the literature, this likely heterogeneous population of 
exosomes and small micro-vesicles are referred to non-specifically as small extracellular vesicles (sEVs), based 
on a previous designation27. Transmission electron microscopy further demonstrated the presence of sEVs with 
diameters above and below the mean particle size (Fig. 1d). sEVs also exhibited heterogeneity in both EV diame-
ter and the presence of electron dense regions, which were observed primarily in the region of the cell membrane 
(Fig. 1e, white arrows), suggesting localised mineral aggregation.
sEVs derived from mineralising osteoblasts enhanced the differentiation of human bone mar-
row mesenchymal stem cells when compared with the current gold standard. We sought to 
determine whether electron-dense sEVs derived from mineralising osteoblasts, henceforth referred to as miner-
alising osteoblast-derived extracellular vesicles (MO-EVs), were able to promote mineralisation when added to 
hBMSC cultures, and how these compared against sEVs derived from non-mineralising osteoblasts (NMO-EVs), 
a positive control (mineralisation medium only) and the current gold-standard, BMP-2. For the generation of 
sEVs, cell seeding density, culture time and dosage were constant between all treatments.
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When added in the presence of growth medium (GM), levels of alkaline phosphatase (ALP) per cell were 
significantly decreased when compared with the BMP-2 gold-standard in both MO-EV and NMO-EV treated 
hBMSC cultures at days 4, 7 and 14 (Fig. 2a). An inverse pattern was found when EVs were administered in the 
presence of mineralisation medium (MM), with significantly elevated ALP levels observed in both MO-EV- and 
NMO-EV-treated hBMSC cultures at days 4 and 7 when compared with the MM control (Fig. 2b). In the presence 
of MM, cellular levels of ALP were not found to be significantly different in the EV treatment cultures compared 
to the BMP-2 gold-standard.
Alizarin red (AR) staining and X-ray fluorescence (XRF) elemental mapping revealed only limited calcium 
deposition when NMO-EVs and MO-EVs were added in the presence of growth medium (GM) (Fig. 2c and d). 
XRF maps when displayed in absolute mode, where the Ca and P intensities are normalised to the highest inten-
sity elemental peak detected in the complete map, showed that calcium levels were enhanced if NMO-EVs were 
administered in the presence of MM when compared with GM. Visually, levels of calcium in these cultures 
resembled those observed the MM control and the BMP-2 gold-standard (Fig. 2d). The addition of MO-EVs 
in the presence of MM resulted in large areas of calcium deposition when visualised by AR staining and XRF 
under absolute mode (Fig. 2d). Observation of these cultures under relative mode (Fig. 2d row i), where the 
Ca and P intensities are normalised to the highest intensity of Ca and P in the map, highlighted areas of Ca and 
P co-localisation (yellow) were present only in MO-EV/MM-treated cultures. Calcium deposition in MO-EV/
GM, NMO-EV/MM and GM, BMP-2 and MM cultures appeared to be diffuse and lacked the intensely fluores-
cent agglomerations observed in MO-EV/MM cultures (Fig. 2d row ii). Limited co-localisation of Ca and P was 
observed in these cultures suggesting that both elements were not associated with a mineral phase but rather as 
isolated components. Phosphorus was found to be ubiquitously expressed in all samples and was considered to 
largely identify the presence of phospholipids in the hBMSC cellular membranes (Fig. 2d row iv). However, visual 
differences in P were observed between hBMSCs exposed to GM and MM, with those exposed to MM displaying 
enhanced P intensity and linking these increases to the presence of mineral and a residual beta-glycerophosphate 
presence (Fig. 2d).
Figure 1. Profiling and characterisation of sEVs derived from mineralising osteoblasts (MO-EVs). (a) 
Topographic profiling of sEVs using AFM under tapping mode revealed a heterogeneous population of 
spherical particles with sizes within the range previously obtained for osteoblast EVs (<300 nm). (b) Tunable 
resistive pulse sensing measurements revealed a mean particle size of 167 nm, with a maximum particle size 
of 340 nm. (c) DLS measurement also confirmed a largely mono-disperse population with a mean particle size 
of 157 nm. (d) Transmission electron micrograph identifying a heterogenous population of sEVs with white 
arrows identifying the presence of what appear to be membrane-associated condensations associated with 
mineral accumulation.
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Figure 2. Examining the osteoinductive effects of MO-EVs on whole hBMSC cultures when compared with 
the current gold-standard, BMP-2. For all experiments the osteoinductive effects of MO-EVs were evaluated in 
growth medium and mineralisation medium (MM). MO-EVs were compared with NMO-EVs and BMP-2. ALP 
levels were measured at days 4, 7, and 14 in the presence of (a) growth medium (GM) and (b) mineralisation 
medium (MM). ALP levels were significantly elevated in MO-EV and NMO-EV treated cultures at days 4 and 
7 only in the presence of MM. (c) Alizarin red calcium staining of hBMSC cultures at days 7 and 14 of culture 
with corresponding whole plate images displayed in the bottom right hand corner. Comparatively large areas 
of calcium deposition were observed in the hBMSC cultures treated with MO-EV/MM when compared with 
all other treatments. (d) X-ray fluorescence (XRF) elemental mapping confirmed the presence of comparatively 
large areas of calcium (red) deposition in MO-EV/MM treated cultures. XRF images are provided in (i) relative 
mode to distinguish areas of Ca (red), P (green) and co-localisation (yellow), and (ii) absolute mode to best 
represent how much Ca and P contribute to the total elemental composition of the sample. Alizarin red images, 
scale bars represent 300 μm. XRF images, scale bars represent 900 μm. N = 3.
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sEVs derived from mineralising osteoblasts act as extracellular sites of mineral nucleation 
within the developing matrix. In order to define the organic and inorganic components of the ECM envi-
ronment within the calcium-rich MO-EV/MM-treated hBMSC cultures we performed Fourier-transform infra-
red spectroscopy (FTIR) analysis within the 650–1700 cm−1 spectral range. The spectra were found to contain 
several vibrational bands representing components within a mineralising ECM, such as ECM proteins, lipids and 
P-O bonds of PO43− ions. Normalisation of the FTIR spectra using the Standard Normal Variate (SNV) method 
and auto-scaling of the spectra enabled comparison of relative peak heights across the samples while mini-
mising the influence of varying sample thickness. The vibrational amide I (1650–1700 cm−1), amide II (1530–
1575 cm−1) and amide III (centred at 1240 cm−1) indicative of ECM proteins were detected in both MO-EV 
samples (Fig. 3a)28–31. However, in hBMSC cultures dosed with MO-EV that had been administered in the pres-
ence of MM (MO-EV/MM), a significant enhancement in amide peaks was noted. This included broadening 
of amide I and II peaks, as well as an increased intensity in the amide III peak (Fig. 3a, blue line). Furthermore, 
the intensity of the amide peaks collectively relative to the P-O peaks was higher than that of MO-EV exposed 
to hBMSC cultures in the presence of growth media (GM) (Fig. 3a, red line), suggesting a higher abundance of 
matrix proteins. It should be noted that IR frequencies and their relative contribution within the amide band 
depends upon on collagen conformation and the level of hierarchical structure present – particularly in the case 
of collagen. We acknowledge some shift in amide bands that are likely to be indicative of conformational changes 
related to an increased presence of Ca2+ in MO-EV/MM-treated hBMSC cultures. Relative enhancement could 
also be observed in the stretching P-O bond of PO43− (1080, 1035–1045 cm−1). Further increases in the primary 
P-O-C absorption band (1060 cm−1) and a P = O bond of phospholipids (1250 cm−1) were observed, which was 
attributed to the presence of characterised sEV membrane components, such as phosphatidylserine (Fig. 3a)30,31. 
While amorphous calcium phosphate (ACP) and octacalcium phosphate (OCP) have vibrational modes within 
this region, OCP was ruled as being the dominant phase given that the most intense band for OCP is typically 
located around ~1025 cm−1 and this peak was found be to significantly weaker in these experiments compared 
to the 1060 cm−1 in question. ACP is usually characterised in FTIR spectra a by broad single peak spanning 900–
1200 cm−1. While the spectra in our case exhibit significant peak broadening, fine peaks are clearly discernible 
within this region suggesting the presence of other compounds in addition to a possible ACP phase.
Pairwise comparison of FTIR spectra made between hBMSC cultures treated with MO-EV/MM and the 
BMP-2 gold standard revealed overlap between primary, secondary and tertiary amide peaks but highlighted a 
relative increase in presence of PO4 mineral phase and phospholipids (P-O-C, 1060 cm−1; P = O, 1250 cm−1) in 
MO-EV/MM samples (b). Notably, a small shoulder located at 1025 cm−1 indicative of OCP30,32 was present in 
both hBMSC cultures exposed to MO-EV/MM and BMP-2 (Fig. 3b).
At this stage we acknowledged the limitation of analysing a bulk FTIR spectrum of the MO-EV in MM culture 
given the clear evidence in the XRF maps that this culture exhibited a highly heterogeneous chemical composi-
tion, with large regions highly enriched in Ca with relatively little P and smaller areas of Ca and P colocalisation. 
Figure 3. FTIR characterisation of organic and inorganic components of the hBMSC ECM. Pairwise 
comparison of FTIR spectra within the 675–1700 cm−1 spectral range using the standard normal variate (SNV) 
method for hBMSC cultures treated with (a) MO-EV/GM vs. MO-EV/MM, (b) BMP-2/MM vs. MO-EV/MM, 
and (c) regions within MO-EV/MM. Principal component analysis (PCA) was applied to define how mineral 
was associated with the ECM (d).
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The mean spectra of three sub-regions within the MO-EV/MM micro-XRF readout were compared. These com-
prised of regions of elemental Ca and P co-localisation, Ca-rich regions, and regions where there was little Ca 
or P (Fig. 3c). There was little difference in the inorganic composition of the regions low in Ca and P and those 
rich with Ca. The only features noted were enhancement of the amide I peak relative to P-O peaks and a broad 
weak shoulder forming between 1090–1150 cm−1 in the Ca-rich region. The regions of Ca and P colocalisation 
showed substantial decrease in the intensity of P-O, OCP and P-O-C peaks relative to the amide and CH2 peaks, 
although the OCP shoulder was still clearly visible. A new peak around 1092 cm−1 was identified along with some 
weak shoulder peaks between 1120–1132 cm−1, which are believed to correspond to HPO42−. These ions are most 
likely to be within the OCP phase, but can also more generally relate to apatitic phases. The strong Ca signal in the 
micro-XRF maps yet weak FTIR peaks suggests that a sizable fraction of the Ca might be associated with organic 
matter at this early stage of mineralisation.
FTIR maps (relative mode) of the organic matter and OCP were generated in order to define how the mineral 
phase associated with the developing ECM in the MO-EV MM culture (Fig. 3d). The map of the protein matrix 
(red map) showed intense pixel intensity over the entire culture area. OCP (green map) did not map exclusively 
with the protein matrix and was found to correlate more strongly with the regions where the strong Ca was seen 
in the micro-XRF map. The signal from phospholipids (blue map) correlated very strongly with the presence of 
OCP, thus suggesting the developing mineral component was primarily associated with phospholipid and not 
directly associated with the collagenous matrix.
The proteome of MO-EVs is enriched in binding proteins with roles in cell adhesion and extra-
cellular matrix organisation. The proteomes of MO-EVs and NMO-EVs were compared for three 
independent sample preparations using a label-free MS-LC/LC approach. The use of stringent criteria only 
permitted the inclusion of proteins identified in at least two biological replicates, with >2 spectral counts (SC) 
in at least one repeat. Protein database searching resulted in the identification of a total of 154 proteins. Of 
these, 117 proteins were found to be shared between MO-EVs and NMO-EVs, 34 were specific to MO-EVs, 
and 3 were specific to NMO-EVs (Fig. 4a). A strong MS/MS peak intensity correlation was evident between 
the shared protein profiles of NMO-EVs and MO-EVs, with an average Pearson correlation coefficient of 0.899 
(Supplementary information, S2).
Consistent with the derivation of the sEVs obtained in this study, both NMO-EVs and MO-EVs contained 
endosome-associated proteins, including Rab GTPases (Rab11a), common metabolic enzymes (Eno1, Pkm, 
GAPDH), Heat shock proteins (HSP90ab1, HSPa1a), membrane transport proteins (Anxa2, Anxa4, Anxa5, 
Anxa6), cytoskeletal components (Acta1, Actb, Tuba1b, Tuba4a, Tubb5, Cfl1), membrane adhesion proteins 
(Itgb3, Itga2b), signal transduction protein kinases (Marcks, Pgk1), common proteins related to apoptosis 
Figure 4. Gene ontology (GO) analysis of proteins found to be exclusive to or significantly upregulated in 
MO-EVs. (a) Venn diagram comparing the proteomes of MO-EVs with that of NMO-EVs identified a total 
of 117 shared proteins, 34 proteins exclusive to MO-EVs and 3 proteins that were exclusive to NMO-EVs. GO 
prediction of the (b) cellular compartment (c) biological function and (d) molecular mechanism of proteins 
significantly upregulated or exclusive to MO-EVs identified vesicular and extracellular matrix binding proteins 
with principal roles in cell adhesion and extracellular matrix organisation. The top ten most significant hits are 
presented for each GO designation. N = 3.
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(histones), anti-apoptotic proteins (Lgals1), and the tetraspanin protein CD81. A comprehensive list of com-
mon EV marker proteins and their relative abundance in NMO-EV and MO-EV samples can be found in the 
Supplementary information (S2). Specifically, this study highlighted possible differences in commonly used, yet 
not fully standardised EV surface membrane marker proteins between NMO-EVs and MO-EVs. Although fur-
ther analysis, which lies outside the scope of the present study, will be required to confirm these differences, they 
may represent an effective way to select for vesicles that have the capacity to induce matrix mineralisation. These 
proteins comprised of members of the tetraspanin protein family (CD9), programmed cell death 6 interacting 
protein (PDCD6ip) and heat shock protein 90 alpha family class A member 1 (HSP90aa1).
To provide an overview of the principal processes, mechanisms and cellular location of proteins exclusive 
to or significantly upregulated in MO-EVs Gene Ontology (GO) analysis was performed. Cellular compart-
ment prediction confirmed that these proteins were confined to EVs and extracellular environment (Fig. 4b). 
Biological process analysis indicated that these proteins primarily functioned in cell adhesion and organisa-
tion of the extracellular matrix (Fig. 4c). Molecular mechanisms of these proteins, included protein- and cal-
cium ion-binding (both calcium-dependent and calcium-independent), as well as roles in the binding of other 
membrane-associated molecules, such as lipids and phospholipids (Fig. 4d).
Calcium-binding proteins, osteoblast-bridging collagens and regulators of ECM mineralisa-
tion are implicated in the potent osteoinductive effects of MO-EVs. Lastly, we sought to further 
define proteins that may be responsible for the potent osteoinductive effects of MO-EVs. Proteins identified by 
LC-MS/MS were compared by correlating differences in Log2 values of fold-protein change between MO-EVs 
with NMO-EVs and plotting these against the false discovery rate (FDR). Of the total number of proteins found 
to be significantly upregulated in MO-EVs, 27 of these exhibited a fold-change of >2. Application of these strin-
gent selection criteria was applied to distinguish only the most significant proteins likely to be associated with 
MO-EV enhanced hBMSC mineralisation (Fig. 5a). The 27 proteins identified as being significantly up-regulated 
in MO-EVs, included cytosolic proteins involved in signal transduction (Sdcbp, P < 0.05), osteogenesis (Spp1, 
P < 0.001), collagen modification (Pcolce, P < 0.01), calcium binding (Anxa-1, P < 0.05; Anxa-2, P < 0.01 and 
Anxa-6, P < 0.05), intracellular ATP generation (Nme2, P < 0.05), bridging collagens involved in osteoblast inter-
actions (collagen type-VI α1, 2 and 3, P < 0.01), the calcium-binding messenger protein (Calm1, P < 0.05), a 
major nucleolar protein (Ncl, P < 0.0001), and the vitamin K-dependent protein S (Pros1, P < 0.001). A compar-
ison of the relative MS/MS peak intensities of proteins considered to be most related to MO-EV mineralisation 
Figure 5. Analysis of differentially expressed proteins identified using LC-MS/MS between MO-EVs and 
NMO-EVs. (a) Volcano plot displaying Log2 values for protein fold-change against Log10 FDR. Proteins with a 
Log2 fold difference below 1 and a statistical value of >0.05 (horizontal dashed line) were not considered to be 
statistically significant. Proteins found to be significantly upregulated in MO-EVs are displayed in red. Proteins 
that were significantly upregulated in NMO-EVs are displayed in green. Graphical representations of LC-MS/
MS signal intensity plots for proteins found to be differentially expressed within (b) MO-EVs and (c) NMO-
EVs. *, **, *** and **** signify P values of <0.05, <0.01, <0.001 and <0.0001, respectively. N = 3.
www.nature.com/scientificreports/
8SCientifiC REpORTs | 7: 12639  | DOI:10.1038/s41598-017-13027-6
are presented in Fig. 5b. A comprehensive list delineating all proteins significantly up-regulated in the MO-EV 
fraction can be found in the supplementary information. In contrast, only 4 proteins were found to be signif-
icantly (P < 0.05) upregulated in NMO-EVs. These consisted of the extracellular matrix glycoprotein tenascin 
(Tnc), histone H1.3 (Hist1h1d), collagen type-I alpha2 (Col1a2) and collagen type-XII alpha1 (Col12a1). A full 
list of proteins identified as specific to- or significantly upregulated in MO-EVs is presented in the Supplementary 
information (S3). Of note is the fact that phosphatase enzymes, alkaline phosphatase (ALP) and ectophosphodi-
esterase nucleotide pyrophosphatase (enpp) were not identified on either NMO-EVs or MO-EVs.
Discussion
The majority of investigations into the osteoinductive effects of osteoblast-derived vesicles have been confined to 
those bound within the ECM (MVs). Relatively few studies have examined the roles of small extracellular vesicles 
released into the culture medium (sEVs). From a therapeutic perspective EVs have considerable benefits over 
MVs as they can be simply isolated without the need for time consuming ECM digestion that could potentially 
have a negative effect on the activity of any bioactive materials within them. In the present study we sought to 
determine whether osteoblast-derived sEVs could be utilised as an acellular yet biologically inductive method for 
inducing human stem cell differentiation and define the underlying biochemical mechanisms involved.
The present study provides comprehensive evidence to show that the culture environment in which 
osteoblast-derived sEVs are generated is of critical importance if they are to be successfully applied to induce 
hBMSC differentiation towards a mineralising phenotype. Significant differences in the capacity of sEVs to induce 
hBMSC mineralisation was observed between NMO-EVs and MO-EVs, with only the administration of MO-EVs 
in the presence of MM found to greatly enhance the deposition of calcium in the surrounding ECM (Fig. 2). 
The fact that MO-EVs only enhanced matrix mineralisation in the presence of MM led to the hypothesis that 
sEVs continued to accumulate calcium and phosphorus ions required for mineralisation within the developing 
ECM. The question of whether osteoblast-derived vesicles are preloaded with calcium and phosphorus at the 
time of their release or whether these vesicles accumulate ions extracellularly has long been of interest33. There 
is a collective body of evidence to demonstrate that both mechanisms occur in vivo, with the presence of both 
electron lucent and electron dense sEVs observed at progressing stages of matrix mineralisation. Distinctions 
in the genesis of vesicle subtypes lend further support to these findings. For instance, small endocytic vesicles 
termed exosomes have been shown to accumulate Ca2+ and P intracellularly through association with organelles, 
such as the mitochondria, while the extracellular accumulation of Ca2+ and PO43− ions has been posited to be a 
feature of micro-vesicles that bud directly from the cellular plasma membrane and subsequently associate with 
the collagenous ECM34. Here, TEM evidence demonstrates that sEVs derived from the medium of mineralising 
osteoblast cultures facilitate the transport of electron-dense material (Fig. 1e). However, it is hypothesised that a 
large subsection of these unbound vesicles also continue to accumulate ions extracellularly and that this is critical 
for the sEV-induced mineralisation of hBMSC cultures. This data acts to highlight heterogeneity in the sEV pop-
ulation, which was fractioned based on differential centrifugation and will certainly comprise of exosomes as well 
as larger microvesicles. Given that the present study has provided evidence to show that a heterogeneous popu-
lation of MO-EVs is efficacious for inducing hBMSC mineralisation, an important next step will be to separate 
exosomes from small micro-vesicles to determine the independent osteoinductive effects of each sub-population 
on stem cells. Furthermore, LC-MS/MS data presented in the present study suggested that, unlike matrix-bound 
vesicles, both NMO-EVs nor MO-EVs derived from the culture medium lacked phosphatase enzymes required 
to process exogenous beta-glycerophosphate added to the culture environment (Supplementary Figure, S3). This 
led us to conclude that enhanced cellular ALP expression identified in our study was essential for facilitating the 
generation of inorganic phosphates that could associate with MO-EVs within the extracellular environment, 
co-localising with calcium to drive mineral formation.
Although evidence implicating EVs as an initial site of early mineralisation within developing bone has long 
been postulated, the mechanisms by which EVs initiate matrix mineralisation are not entirely clear12,13. There is 
evidence identifying vesicle association with the collagenous ECM and the subsequent deposition of an amor-
phous calcium phosphate (ACP) as a potential mechanism for advancement of the mineralisation front within the 
growth zones of developing bone35. Although, the biochemical processes governing the formation of biological 
apatite are not fully understood, more soluble calcium phosphate phases have been implicated as precursors in its 
formation. Evidence has existed since 1957 to suggest that these are subsequently transformed into a more stable 
and less soluble apatitic phase in a thermodynamically favoured process36. However, much debate still surrounds 
this hypothesis and, to date, evidence has only been provided by a small number of in vivo studies, such as the 
evolving zebrafish bone model35. The present study provides evidence of a transitioning mineral phase, identified 
using FTIR as octacalcium phosphate (OCP), in hBMSC exposed to MO-EVs after just 14 days culture (Fig. 3). 
Metastable OCP has long been regarded as near-terminal transitional phase in the formation of biological apatite 
that occurs only under more acidic conditions37. Using micro-XRF and FTIR mapping combined with statistical 
processing of the spectra (Fig. 3d), we were able to deduce that rather than being principally associated with the 
collagenous ECM, OCP was localised to the P-O-C component of phospholipid, known to be enriched in the 
EV membrane30,31,38. The continued association of this transitioning mineral component with the EV membrane 
within the ECM would indicate that early mineral nucleation largely occurs in association with the phospholipid 
membrane of the maturing EVs. This hypothesis is further supported by previous studies that have shown EVs are 
typically found to be of a more acidic pH, facilitating fusion with the membrane of recipient cells39,40 and limiting 
the dissolution of metastable OCP. However, further experimental research is required to elucidate the process of 
mineral nucleation and crystallisation on the phospholipid-rich membrane of EVs. Currently, evidence required 
to convincingly demonstrate the transition of mineral to a stable apatite from an amorphous precursor is lacking 
due to the transience of each phase during in vivo osteogenesis that is further confounded by difficulties in vis-
ualising these mineral phases41.
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In order to further support the hypothesis that mineral nucleation is initially confined to the phospholipid-rich 
inner membrane of sEVs, the entire protein component of MO-EVs and NMO-EVs were profile to identify pro-
teins required for the chelation of mineral ions and the advancement of mineral formation (Fig. 5). Annexins rep-
resent a well characterised group of Ca2+ chelators that interact with phospholipids, including phosphatidylserine 
(PS) within the inner EV membrane to from PS-Ca2+-P complexes, which act as a centre for the crystallisation 
and nucleation of mineral on an osteoid template42. It has previously been shown that the presence of OCP was 
largely associated with the EV phospholipid membrane, which is thought to act in conjunction with calcium 
chelating proteins and orthophosphate as an intraluminal site for mineral nulecation43. In the present study it is 
shown that annexins A1, A2 and A6 are significantly upregulated in MO-EVs when compared with NMO-EVs, 
contributing to an inner nucleational core that is, at least in part, likely to be responsible for the delivery and 
propagation of mineral within the surrounding matrix of hBMSC cultures44,45. Previous studies have described 
the presence and enrichment of annexins within matrix-bound vesicles (MVs) and their importance in events 
such as pathological mineralisation is well demonstrated46. However, the presence of these Ca2+ binding proteins 
in osteoblast-derived EVs has been described by only a limited number of groups26. Within osteoblast cultures, an 
increase in the expression of annexin I has been associated with enhanced ALP activity and PTH-induced cAMP 
stimulation47. Subsequent analysis of the role of annexins in osteoblast-mediated mineralisation identified that 
these increases in alkaline phosphatase activity were localised to lipid rafts that subsequently become internalised 
within endosomes and exported in small EVs (<200 nm) called exosomes48,49. However, the significant roles that 
these calcium-binding proteins may play during bone formation, on the whole, been largely overlooked47. Given 
our findings it is possible that significant up-regulation of annexin proteins observed in MO-EVs is likely to have 
an important role in binding of extracellular calcium ions, acting as a site for mineral nucleation and contributing 
to the significantly increased mineralisation status of hBMSC cultures in the presence of MM.
In addition to an increase in the presence of Ca2+ chelating annexin proteins, evidence is presented to indi-
cate that the type of collagen associated with EVs is temporally dependent on the mineralisation status of the 
osteoblast (Fig. 5). Given their size, these larger ECM components are thought to be anchored to EVs via various 
binding proteins rather than being localised within the EV lumen50. Both vesicles-derived from mineralising and 
non-mineralising osteoblasts were found to contain collagen-binding proteins, such as protein disulphide isomer-
ase, which may serve to anchor collagens to the EV and provide a mechanism of transit from the endoplasmic 
reticulum to the ECM51. Intriguingly, MO-EVs were found to be significantly enriched with collagen type-VI but 
were less associated with collagens type-Ia and -XII when compared with NMO-EVs. The contribution of col-
lagen type-I to mineralisation is well described and it represents the major ECM component of bone. However, 
osteogenesis is a complex process that requires the contribution of other structurally distinct, and frequently 
overlooked, collagens. Collagen type-VI (non-fibrillar) and -XII (fibrillar) have coordinated roles in the forma-
tion of collagen bridges involved in osteoblast cell-cell communication, with the deletion of these genes leading to 
a reduction in bone mass and increased fragility52. Collagen-VI is a primary component of the periosteum ECM 
that is thought to function in early osteoblast differentiation and formation of the primary osteon53,54. Receptors 
for collagen-VI are found on the surface of chondrocytes and have been shown to transduce signals to the mito-
chondria and having important roles in the release of mitochondrial Ca2+, which is subsequently packaged into 
endosomal vesicles and delivered into the extracellular environment55. Collagen-XII contains several domains, 
specifically one collagenous domain that interacts with collagen-I and another large N-terminal globular domain 
that has been shown to interact with molecules, such as tenascin, which regulate cellular interaction with the sur-
rounding pericellular matrix, influencing osteoblast adhesion and differentiation, and which was found here to be 
significantly upregulated in NMO-EVs56. To our knowledge, this study presents the first indication that the depo-
sition of these bridging collagens is, at least in part, coordinated by the extracellular delivery of osteoblast-derived 
EVs and that the transfer of these collagens is likely temporally distinct.
Other proteins that were found to be significantly up-regulated in MO-EVs also warrant some brief discus-
sion, since their contribution may have important implications for early mineralisation that demand further 
investigation. The majority of these proteins function in the binding of calcium ions and as intracellular messen-
gers but have under characterised roles during early osteogenesis. These proteins included nucleolin, calmodu-
lin and protein-S. Nulceolin is a nuclear phosphoprotein that has previously been shown to be translocated in 
small matrix vesicles to the cell surface57. Although the relationship between nucleolin and osteogenesis remains 
unknown, there is evidence to suggest this calcium-binding protein is linked to cartilage matrix degradation 
through MMP-9 and the relaying of signals to the ECM and nucleus58. A second calcium-binding protein found 
to be up-regulated in MO-EVs was calmodulin, which is activated through the binding of calcium ions and func-
tions in the Ca2+ signal transduction pathway that enhances osteoblast differentiation and bone development59. 
Finally, a protein that was found to be significantly up-regulated in MO-EVs yet largely uncharacterised in rela-
tion to osteogenesis is the vitamin-K-dependent protein, protein-S. Unlike nucleolin and calmodulin, protein-S 
does not function in the binding of calcium ions. Members of the vitamin-K-dependent protein family have well 
defined roles in osteogenesis as well as in pathological vascular calcification. Currently, little information exists 
regarding the role of protein-S during osteogenesis. However, it has previously been hypothesised that this protein 
may be as important as other well characterised vitamin K-dependent proteins, such as osteocalcin and matrix 
gamma-carboxyglutamic acid (Gla) protein, in bone turnover60. It is recommended that further examination of 
this protein is required in order to better define its role during early osteogenesis.
In conclusion, data is provided to show that sEVs derived from mineralising osteoblasts have considerable util-
ity as an acellular approach to mineralised tissue engineering. Interestingly, the contents of these vesicles appear to 
be dependent on the culture environment in which they are generated, with sEVs derived from non-mineralising 
osteoblasts demonstrating limited efficacy in vitro. Comparative proteomic analysis of MO-EVs and NMO-EVs 
highlighted significant up-regulation in the presence of calcium chelating proteins, namely annexins, that have 
been shown to have important yet under-characterised roles in the EV-localised mineral nucleation, as well as 
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bridging collagens previously shown to be important in the formation of the early mineralising ECM. Lastly, since 
the mineral identified was defined as OCP and found to be primarily associated with phospholipid, it is proposed 
that this likely represented a transitioning mineral phase that continued to remain in contact with EVs even 
within the developing ECM. Perhaps one of the most striking findings, and a further reason to hypothesise that 
EVs acted as an early site of mineral nucleation, was that MO-EVs were only capable of significantly enhancing 
mineralisation when added in the presence of MM. This suggests that exogenous ions within the medium became 
associated with the MO-EVs extracellularly - likely due to the enhanced presence of annexins - and were required 
for the formation of OCP in these cultures.
Materials and Methods
Cell Culture and Reagents. Human bone marrow-derived mesenchymal stem cells (hBMSCs) were pur-
chased from Lonza (Lonza, UK http://www.lonza.com). hBMSCs were fully profiled for the expression of CD29, 
CD44, CD105 and CD166 and lack of CD14, CD34, CD45. MC3T3 murine osteoblasts were purchased from 
America Type Culture Collection (ATCC, http://www.atcc.org). Cell culture medium comprised of minimal 
essential medium (α-MEM; Sigma-Aldrich, UK) supplemented with 10% foetal bovine serum (FBS), L-glutamine 
(Sigma-Aldrich, UK) and 1% penicillin/streptomycin (Sigma-Aldrich, UK). hBMSCs were used between passage 
4–5. Mineralisation medium was formulated through the addition of 10 mM β-glycerophosphate (Sigma-Aldrich, 
UK) and 50 μg/mL L-ascorbic acid (Sigma-Aldrich, UK). Culture medium used for EV isolation was depleted of 
any contaminating EVs by ultra-centrifuging the FBS at 120,000 g for 70 minutes prior to use.
Exosome Isolation and Characterisation. MC3T3 osteoblasts were cultured at scale in T175 culture 
flasks (Nunc, UK) and the medium isolated every two days. Osteoblasts were grown in either standard culture 
medium or osteogenic medium for a total period of 14 days. Osteoblast-derived EVs were isolated from collected 
medium by differential centrifugation: 2000g for 20 minutes to remove cell debris and apoptotic bodies, 10,000 g for 
30 minutes to remove micro-vesicles, 120,000 g for 70 minutes to pellet EVs. Following the final ultracentrifugation 
step, the supernatant was removed, the pellet washed in sterile phosphate buffered saline (PBS) and further centri-
fuged at 120,000 g. All ultracentrifugation steps were performed using a Sorvall WX Ultra Series Ultracentrifuge 
(Thermo Scientific, UK) with a Fiberlite, F50L-8 × 39 fixed-angle rotor (Piramoon Technologies Inc., USA).
The resulting pellet was re-suspended in 200 μL of PBS and the total protein concentration determined 
using the Pierce BCA protein assay kit (Thermofisher Scientific, UK, http://www.thermofisher.com). Particle 
size distribution was analysed using Dynamic Light Scattering (DLS; Malvern Instruments, UK) and quanti-
tated using resistive pulse sensing (IZON qNano) and nanoparticle tracking analysis (Nanosight LM10; Malvern 
Instruments, UK).
Atomic Force Microscopy. 5 μL of EV suspension was adsorbed onto freshly cleaved mica sheets and left 
to dry at 4 °C overnight. Samples were rinsed with deionised water and left to dry naturally in a flow hood. 
The presence of exosomes was determined using a NanoWizard II atomic force microscope (JPK Instruments, 
Germany) under tapping mode using FESP cantilevers (Bruker, Germany). Images were acquired using a scan 
rate of 0.25 Hz. Image processing was performed using JPK data processing software.
Transmission Electron Microscopy. A suspension of EVs was made in sterile PBS. A single drop of the 
suspension (~20 μL) was deposited onto a carbon film grid (Agar Scientific, UK) and left to air dry for a period of 
1 minute. To remove excess PBS the grid was gently blotted using tissue paper through capillary action. Negative 
staining was achieved by placing a single drop (~20 μL) of uranyl acetate solution onto the dry grid. Samples were 
imaged using a JEM 3200FX transmission electron microscope (Joel, USA) using a voltage of 80 kV.
Stem cell culture in the presence of EVs. hBMSCs were seeded in 6 well culture plates (Nunc, UK) 
at a density of 21 × 103 cells per cm2 and incubated at 37 °C, 5% CO2 to allow cell attachment. After 24hrs the 
medium was replaced with EV-free medium in the presence and absence of mineralisation suppliments, 10 mM 
β-glycerophosphate (Sigma-Aldrich, UK) and 50 μg/mL L-ascorbic acid (Sigma-Aldrich, UK). EVs were added to 
each well at a concentration of 10 μg/mL. Medium changes and EV replenishment was performed every 48 hrs. As a 
positive control, MSCs were exposed to mineralisation medium in the absence of EVs. As a gold-standard compari-
son, MSCs were cultured in the presence of BMP-2 and MM, since BMP-2 is a commercially available and clinically 
applied growth factor shown to induce mineralisation in vitro61 and in instances of non-union and spinal fusion62.
Alkaline Phosphatase Assay. Cellular alkaline phosphatase (ALP) levels were quantified using the 
SensoLyte® pNPP Alkaline Phosphatase Assay Kit (AnaSpec, USA) according to the manufacturer’s instructions. 
Briefly, cell monolayers were washed twice using 1x assay buffer provided. Cells were detached from the surface of 
the culture plate in the presence of 200 μL permeabilisation buffer using a cell scraper. The resulting cell suspension 
was collected in a microcentrifuge tube, incubated at 4 °C for 10 minutes under agitation, and then centrifuged at 
2500 g for 10 minutes. Supernatant was transferred to a 96 well plate where it was combined with an equal volume 
of pNPP substrate. Absorbance was measured at 405 nm using a GloMax Multi Plus spectrometer (Promega, UK).
Alizarin Red Staining and Quantification. Calcium-rich deposits were visualised using 40 mM alizarin 
red (Sigma-Aldrich, UK) stain, which was dissolved in acetic acid and adjusted to pH 4.2 using 5 M ammonium 
hydroxide.
Micro-XRF mapping of cell cultures. Samples for analysis were prepared by transferring mineralised cell 
monolayers onto an aluminium foil covered glass slide and leaving to dry overnight at room temperature. Maps 
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of calcium and phosphorous across dried cell culture media spot samples were acquired using a Tornado M4 
micro-XRF system (Bruker Nano, Germany) fitted with a Rhodium micro focus X-Ray tube and a polycapillary 
lens, with the X-ray tube set to 50 kV voltage and 300 μA current. The chamber pressure was lowered to 20 mbar 
in order to maximise sensitivity to the phosphorus signal. The system was programmed to acquire a map of 
the whole slide containing all of the media spot samples by rastering the microfocus beam over the slide with 
a step size of 30 μm and a time per pixel of 30 ms. An XRF spectrum was collected at each pixel and elemental 
maps generated progressively in real time by gating around the phosphorous Kα1 (2.0137 keV) and calcium Kα1 
(3.692 keV) X-Ray fluorescence peaks in the spectra, creating an image where pixel intensity represented X-Ray 
detector pulses per eV at each measurement point on the sample. Maximum pixel intensity for each element was 
normalised to the peak pulses/eV value for that element across the whole sample.
Infrared mapping of EV-treated hBMSCs. Cell monolayers were carefully transferred from culture 
dishes and spotted on to an aluminium coated glass slide. Infrared spectroscopy (IR) maps of each spot were 
acquired using a Nicolet iN10 MX Infrared Imaging Microscope, coupled to a liquid nitrogen cooled MCT-A 
Detector with a CdTe window detector, and operated in reflectance mode. The spectral range acquired was 4000 
to 675 cm−1 with a spectral resolution of 4 cm−1, and 64 acquisitions acquired for each spectrum. The aperture size 
was 150 × 150 μm with x and y step sizes of 150 μm. A gold standard was used in spectral background calibration.
Pre-processing of hyperspectral datacubes. Each data file contained a hyperspectral datacube consist-
ing of (x,y) pixel locations across the sample and a third dimension containing a vector of measured absorbance 
values at each wavenumber. Each vector therefore represented the averaged IR spectrum for pixel x,y as collected 
by the instrument. The hyperspectral datacube was imported into MATLAB (MATLAB R2016b, Mathworks, 
Natick, Massachusetts, USA) for pre-processing and analysis using in-house developed code. Each spectrum in 
the data cube was normalised using the Standard Normal Variate (SNV) method, which aids comparison between 
spectra. SNV normalisation processes the spectra such that they are collectively mean centred and divided by 
their own standard deviation as follows:
=
−SNV Spectrum Spectrum x
s
( ) (1)
x = spectrum mean, s = spectrum sample standard deviation.
The resulting spectra had a mean value of zero and a standard deviation of one. Autoscaling was then per-
formed between the equivalently measured wavenumbers of the normalised spectra as follows:
=
−Autoscale Wavenumber Wavenumber x
s
( ) (2)
x = mean of all measured values at wavenumber (between spectra), s = sample standard deviation of all measured 
values at wavenumber (between spectra).
After autoscaling, a final pre-processed spectrum represented measured IR absorbance/transmittance values 
below the mean of all spectra as negative values, and IR absorbance/transmittance values above the mean as 
positive values.
Peak deconvolution. Overlapping IR peaks were deconvoluted into constituent peak shapes and peak loca-
tions estimated through processing in MATLAB. Briefly, the spectra were clipped to include only the spectral range 
where the merged peaks were located and background corrected using a linear background approximation. An ini-
tial guess on the number of Gaussian and/or Lorentzian distributions and their spectral centres to fit to the data was 
made through visual inspection of the spectra. An unconstrained non-linear optimisation algorithm was employed 
to decompose the spectra and optimise the shape and location of the peaks. The objective was to minimise the fit 
error% and maximise R2. The deconvolution process was run multiple times and sometimes the initial guess of the 
number of peaks to fit was changed against visual intuition as a way of searching for potentially more optimal fits.
Mass Spectrometry. Exosome proteins were digested by FASP with LysC and trypsin as described 
previously63.
The peptides generated were then separated by nano-flow reversed-phase liquid chromatography coupled to 
Q Exactive Hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Scientific, UK). Peptides were loaded on a 
C18 PepMap100 pre-column (300 μm I.D. × 5mm, 3 μm C18 beads; Thermo Scientific) and separated on a 50 cm 
reversed-phase C18 column (75 μm I. D., 2 μm C18 beads). Separation was conducted with a linear gradient of 
7–30% B 120 min at a flow rate of 200 nL/min (A: 0.1% formic acid, B: 0.1% formic acid in acetonitrile). All data 
was acquired in a data-dependent mode, automatically switching from MS to collision-induced dissociation MS/
MS on the top 10 most abundant ions with a precursor scan range of 350–1650m/z. MS spectra were acquired at 
a resolution of 70,000 and MS/MS scans at 17,000. Dynamic exclusion was enabled with an exclusion duration of 
40 s. The raw data files generated were processed using the MaxQuant (version 1.5.0.35) software, integrated with 
the Andromeda search engine as described previously64,65.
The MS/MS spectra were searched against the mouse proteome (UniProt 2013/04/03), precursor mass toler-
ance was set to 20 ppm, variable modifications defined as acetylation (protein N-terminus) and oxidation (M), 
carbamidomethylation (C) was defined as fixed modification. Enzyme specificity was set to trypsin with a maxi-
mum of 2 missed cleavages. Protein and peptide spectral matches (PSM) false discovery rate (FDR) was set at 0.01 
and match between runs was applied. Finally, only proteins identified in 2 biological replicates with a minimum of 
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2 spectral counts (SC) in one biological replicate were included for analysis. For proteins to be considered specific 
to either the MO-EV or NO-EV fraction they must have exhibited SC ≥ 5.
Differential protein abundance analysis was performed with Perseus (version 1.5.5.3). In brief, 
Log2-transformed protein intensity distributions were median-normalised and a t-test was used to assess the 
statistical significance of protein abundance fold-changes. P-values were adjusted for multiple hypothesis testing 
with the Benjamini-Hochberg correction66.
Bioinformatic Analysis. The protein annotation through evolutionary relationship (PANTHER, http://
www.pantherdb.org/) classification system (version 9.0) was used for gene ontology (GO) annotation of biologi-
cal pathways, molecular mechanisms and cellular compartments of proteins found to be significantly upregulated 
or specific to MO-EVs.
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